This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Mar;80(3):606-607.

doi: 10.1016/j.jaad.2018.12.039. Epub 2018 Dec 22.

Promoting TERT promoter mutations for prognostication in cutaneous oncology

Warren R Heymann¹

Affiliations

PMID: 30584893
DOI: 10.1016/j.jaad.2018.12.039

Editorial

Promoting TERT promoter mutations for prognostication in cutaneous oncology

Warren R Heymann. J Am Acad Dermatol. 2019 Mar.

. 2019 Mar;80(3):606-607.

doi: 10.1016/j.jaad.2018.12.039. Epub 2018 Dec 22.

Author

Warren R Heymann¹

Affiliation

¹ Division of Dermatology, Cooper Medical School of Rowan University, Marlton, New Jersey. Electronic address: wrheymann@gmail.com.

PMID: 30584893
DOI: 10.1016/j.jaad.2018.12.039

No abstract available

PubMed Disclaimer

Comment on

TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA, Macedo S, Fernandes M, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P. Campos MA, et al. J Am Acad Dermatol. 2019 Mar;80(3):660-669.e6. doi: 10.1016/j.jaad.2018.08.032. Epub 2018 Aug 28. J Am Acad Dermatol. 2019. PMID: 30165166
The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study.
Walton KE, Garfield EM, Zhang B, Quan VL, Shi K, Mohan LS, Haugh AM, VandenBoom T, Yazdan P, Isales MC, Panah E, Gerami P. Walton KE, et al. J Am Acad Dermatol. 2019 Mar;80(3):685-693. doi: 10.1016/j.jaad.2018.09.030. Epub 2018 Oct 1. J Am Acad Dermatol. 2019. PMID: 30287318

Similar articles

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Griewank KG, Murali R, Schilling B, Schimming T, Möller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U. Griewank KG, et al. PLoS One. 2013 Nov 18;8(11):e80354. doi: 10.1371/journal.pone.0080354. eCollection 2013. PLoS One. 2013. PMID: 24260374 Free PMC article.
TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA, Macedo S, Fernandes M, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P. Campos MA, et al. J Am Acad Dermatol. 2019 Mar;80(3):660-669.e6. doi: 10.1016/j.jaad.2018.08.032. Epub 2018 Aug 28. J Am Acad Dermatol. 2019. PMID: 30165166
Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
Cheng KA, Kurtis B, Babayeva S, Zhuge J, Tantchou I, Cai D, Lafaro RJ, Fallon JT, Zhong M. Cheng KA, et al. Ann Diagn Pathol. 2015 Jun;19(3):146-8. doi: 10.1016/j.anndiagpath.2015.03.005. Epub 2015 Mar 17. Ann Diagn Pathol. 2015. PMID: 25862495
Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A, Pellegrini C, Cardelli L, Rocco T, Ciciarelli V, Peris K, Fargnoli MC. Ventura A, et al. Int J Mol Sci. 2019 Mar 16;20(6):1333. doi: 10.3390/ijms20061333. Int J Mol Sci. 2019. PMID: 30884806 Free PMC article. Review.
[Advance on TERT gene in melanoma].
Zheng YX, Zhang X, Su J. Zheng YX, et al. Zhonghua Bing Li Xue Za Zhi. 2024 Jul 8;53(7):762-766. doi: 10.3760/cma.j.cn112151-20231106-00337. Zhonghua Bing Li Xue Za Zhi. 2024. PMID: 38955717 Review. Chinese.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information